Verification evidence is still being completed.
Pure Biologics S.A.
Wroclaw, Poland
- Verified lead
- Filip Jelen
- Lead status
- STATUS: VERIFIED APRIL 2026
- Leadership verification
- Chief Executive Officer and Co-Founder
- 2026 technical specialization
- Antibody and Aptamer Discovery, Immuno-Oncology, and Extracorporeal Apheresis
- Review cycle
- 24 April 2026
- Full address
- ul. Legnicka, Business Garden Wroclaw, Wroclaw, Poland
- Site coordinates
- Verification evidence is still being completed.
- Editorial review
- Memel Biotech editorial review
- Official leadership source
- Pure Biologics team page naming Filip Jelen as CEO and Co-founder.
- Editorial note
- Wroclaw antibody and aptamer biotech with named co-founder CEO, ISO 17025 accreditation, GLP and GMP-capable medium-scale production, and a Business Garden lab facility.
Antibody and Aptamer Discovery, Immuno-Oncology, and Extracorporeal Apheresis
PN-EN ISO 17025, GLP and GMP-capable production, Public team-page CEO disclosure
Wroclaw antibody and aptamer biotech with named co-founder CEO, ISO 17025 accreditation, GLP and GMP-capable medium-scale production, and a Business Garden lab facility.
Wroclaw antibody and aptamer biotech with named co-founder CEO, ISO 17025 accreditation, GLP and GMP-capable medium-scale production, and a Business Garden lab facility.
- Lead
- Filip Jelen (verified ↗)
- Address
- ul. Legnicka, Business Garden Wroclaw, Wroclaw, Poland (source ↗)
- Compliance
- PN-EN ISO 17025 · GLP and GMP-capable production
- Last reviewed
- 24 Apr 2026 (1mo ago)
- Scale
- ISO 17025 plus GMP-capable medium-scale production
- Capabilities
- Antibody Discovery Platforms · PureApta Aptamer Platform · Extracorporeal Apheresis Therapies
- Founded
- 2010
- Headcount
- 51-200
- Company page (open ↗)
Filip Jelen
Chief Executive Officer and Co-Founder
ISO 17025 plus GMP-capable medium-scale production
Wroclaw, Poland. Antibody and Aptamer Discovery, Immuno-Oncology, and Extracorporeal Apheresis. Review completed on 24 Apr 2026.
Polish Office for Registration of Medicinal Products and EMA for future oversight
PN-EN ISO 17025, GLP and GMP-capable production, Public team-page CEO disclosure
Antibody and Aptamer Discovery, Immuno-Oncology, and Extracorporeal Apheresis
Wroclaw antibody and aptamer biotech with named co-founder CEO, ISO 17025 accreditation, GLP and GMP-capable medium-scale production, and a Business Garden lab facility.
Pure Biologics is a Wroclaw antibody and aptamer biotech with a named co-founder CEO, ISO 17025 accreditation, GLP and GMP-capable medium-scale production, and a Business Garden lab facility.
Core capabilities
Primary declared technical activities and areas of operating focus.
Verification source dossier
Official source set used to support leadership, physical-site, certification, and watch-note evidence.
Declared infrastructure
Quality system coverage
GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.
Verification history
Frequently asked questions
- Where is Pure Biologics S.A. located?
- Pure Biologics S.A. operates from ul. Legnicka, Business Garden Wroclaw, Wroclaw, Poland, Wroclaw, Poland.
- Who runs Pure Biologics S.A.?
- Pure Biologics S.A. is led by Filip Jelen, Chief Executive Officer and Co-Founder. Verified 24 Apr 2026.
- What certifications does Pure Biologics S.A. hold?
- Pure Biologics S.A. is documented under PN-EN ISO 17025, GLP and GMP-capable production.
- What does Pure Biologics S.A. do?
- Wroclaw antibody and aptamer biotech with named co-founder CEO, ISO 17025 accreditation, GLP and GMP-capable medium-scale production, and a Business Garden lab facility. Core capabilities: Antibody Discovery Platforms, PureApta Aptamer Platform, Extracorporeal Apheresis Therapies.
Related technical briefs
Briefs that name Wroclaw as a covered market or city.
